Merck Financials

Market Capitalization $203.22 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	11.76
Forward PE	8.61
Price to Sales TTM	$3.18
Price to Book MRQ	$4.21
Enterprise to Revenue	3.51
Enterprise to EBITDA	7.80

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	27.27%
Operating Margin	40.06%
Return on Assets TTM	13.81%
Return on Equity TTM	39.29%

Income Statement

Revenue TTM	$63,921,999,872
Revenue per Share TTM	$25.27
Quarterly Revenue Growth	-1.60%
Gross Profit TTM	$49,265,000,448
EBITDA	$26,593,000,000
Net Income to Common TTM	$17,433,999,360
Diluted EPS TTM	$6.88
Quarterly Earnings Growth YoY	6.70%

Balance Sheet

Total Cash MRQ	$9,228,000,256
Total Cash per Share MRQ	$3.68
Total Debt MRQ	$
Total Debt to Equity MRQ	71.99
Current Ratio MRQ	1.41
Book Value per Share MRQ	$19.21

Cash Flow

Operating Cash Flow TTM	$20,878,000,128
Levered Free Cash Flow TTM	$17,124,249,600

MRK Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	2,527,637,335
Float Shares	2,507,088,934
Avg 10 Volume	21,471,150
Avg 30 Volume	None
Shares Short	35,799,415
Short Ratio	2.50
Short % of Shares	1.59%
% Held by Insiders	0.06%
% Held by Institutions	80.62%

Stock Price Summary

Beta	0.40
Fifty Two Week Low	$73.31
Fifty Two Week High	$129.93
Fifty Two Week Change	-56.25%
Day 50 MA	$79.28
Day 200 MA	$93.24

Dividends and Splits

Forward Annual Dividend Rate	$3.24
Forward Annual Dividend Yield	4.00%
Trailing Annual Dividend Rate	$3.16
Trailing Annual Dividend Yield	3.90%
Payout Ratio	45.93%
Dividend Date	2025-07-08
Ex Dividend Date	2025-06-16
Last Split Factor
Last Split Date	2021-06-03